Literature DB >> 20610306

Acne epidemiology and pathophysiology.

Sheila F Friedlander1, Lawrence F Eichenfield, Joseph F Fowler, Richard G Fried, Moise L Levy, Guy F Webster.   

Abstract

The demographic profile of facial acne vulgaris has changed during the past several decades; 12 years of age is no longer the low end of the "normal" range for onset of acne. The available epidemiologic evidence raises more questions than it answers regarding the etiology of this downward shift. More study is needed to clarify whether the trend toward an earlier onset of puberty in the United States has influenced the clinical picture of acne. Additional research will help advance understanding of the spectrum of pathophysiologic changes in acne in younger pediatric patients and whether it varies from that found in individuals in whom the onset of acne occurs at approximately 12 years of age or later. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20610306     DOI: 10.1016/j.sder.2010.04.002

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  10 in total

1.  Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and benzoyl peroxide (3.75%) aqueous gel in moderate or severe adolescent acne vulgaris.

Authors:  Fran E Cook-Bolden
Journal:  J Clin Aesthet Dermatol       Date:  2015-05

Review 2.  Complementary therapies for acne vulgaris.

Authors:  Huijuan Cao; Guoyan Yang; Yuyi Wang; Jian Ping Liu; Caroline A Smith; Hui Luo; Yueming Liu
Journal:  Cochrane Database Syst Rev       Date:  2015-01-19

3.  A study on the prescribing pattern of drugs for acne in a tertiary care teaching hospital in odisha.

Authors:  Nibedita Patro; Monalisa Jena; Maitreyee Panda; Mrutyunjay Dash
Journal:  J Clin Diagn Res       Date:  2015-03-01

4.  Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris.

Authors:  Michael H Gold; Andrew Korotzer
Journal:  J Clin Aesthet Dermatol       Date:  2015-12

5.  Clindamycin 1% Nano-emulsion Gel Formulation for the Treatment of Acne Vulgaris: Results of a Randomized, Active Controlled, Multicentre, Phase IV Clinical Trial.

Authors:  Bhavik Bhavsar; Bimal Choksi; Jayesh Sanmukhani; Alka Dogra; Rizwan Haq; Sudhanshu Mehta; Santanu Mukherjee; V Subramanian; Shafiq Sheikh; Ravindra Mittal
Journal:  J Clin Diagn Res       Date:  2014-08-20

6.  Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.

Authors:  Haibo Liu; Haiyan Yu; Jun Xia; Ling Liu; Guan J Liu; Hong Sang; Frank Peinemann
Journal:  Cochrane Database Syst Rev       Date:  2020-05-01

Review 7.  Acne and Rosacea.

Authors:  Mauro Picardo; Lawrence F Eichenfield; Jerry Tan
Journal:  Dermatol Ther (Heidelb)       Date:  2017-02-01

8.  The use of isotretinoin in acne therapy in early childhood and its effect on the occurrence of acne symptoms later in life. Eight-year follow-up.

Authors:  Piotr Brzezinski; Uwe Wollina; Janusz Smigielski; Katarzyna Borowska
Journal:  Postepy Dermatol Alergol       Date:  2022-09-01       Impact factor: 1.664

Review 9.  Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents.

Authors:  Christina Huang; Sarah Gold; Rakan Radi; Seth Amos; Howa Yeung
Journal:  Adolesc Health Med Ther       Date:  2022-10-07

10.  Acne vulgaris: prevalence and clinical forms in adolescents from São Paulo, Brazil.

Authors:  Ediléia Bagatin; Denise Lourenço Timpano; Lilia Ramos dos Santos Guadanhim; Vanessa Mussupapo Andraus Nogueira; Luiz Roberto Terzian; Denise Steiner; Mercedes Florez
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.